Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
NIM :
1. Data abnormalitas
Statistics
SGOT_SGP Total
T HB Trigliserida Koresterol HDL LDLq
N Valid 200 200 200 200 200 200
Missing 0 0 0 0 0 0
Mean 26.29 12.47 115.30 137.24 89.44 74.64
Std. Deviation 13.923 .324 20.047 32.405 17.119 13.634
2. EBM DIAGNOSIS
Apakah takipnea sama efektifnya dengan oximetri dalam mengukur hipoksia pada anak
usia 2 bulan.
2.4. search:
https://www.ncbi.nlm.nih.gov/pubmed/?
term=Tachypnoea+is+a+good+predictor+of+hypoxia+in+acutely+ill+infants+under+2
+months.
Tachypnoea is a good predictor of hypoxia in acutely ill infants under 2 months.
Rajesh VT1, Singhi S, Kataria S.
Author information
Abstract
OBJECTIVE:
To evaluate the respiratory rate as an indicator of hypoxia in infants < 2 months of age.
SETTING:
Pediatric emergency unit of an urban teaching hospital.
SUBJECTS:
200 infants < 2 months, with symptom(s) of any acute illness.
METHODS:
Respiratory rate (by observation method), and oxygen saturation (SaO(2)) by means of
a pulse oximeter were recorded at admission. Infants were categorised by presence or
absence of hypoxia (SaO(2) </= 90%).
RESULTS:
The respiratory rate was >/= 50/min in 120 (60%), >/= 60/min in 101 (50. 5%), and >/=
70/min in 58 (29%) infants. Hypoxia (SaO(2) </= 90%) was seen in 77 (38.5%) infants.
Respiratory rate and SaO(2) showed a significant negative correlation (r = -0.39).
Respiratory rate >/= 60/min predicted hypoxia with 80% sensitivity and 68%
specificity.
CONCLUSION:
These results indicates that a respiratory rate > 60/min is
a good predictor of hypoxia in infants under 2 months of age brought to the emergency
service of an urban hospital for any symptom(s) of acute illness.
Comment in
ACP J Club. 2000 Sep-Oct;133(2):69.
Response to Duke et Al. [Arch Dis Child. 2003]
PMID:
10630912
PMCID:
PMC1718185
DOI:
10.1136/adc.82.1.46
[Indexed for MEDLINE]
Free PMC Article
VIA di worksheet
A. VALIDITAS; Apakah Uji diagnostik ini valid?(Are the results of this diagnostic
study valid?)
B. IMPORTANCE (Apakahh uji diagnstik ini penting? (Are the valid results of this
diagnostic study important?)
Sensitivity = a/(a+c)
Specificity = d/(b+d)
CALCULATIONS
Target disorder
Totals
3. EBM TERAPI
P
I
C
O
3.2. Clinical question:
3.4. search:
Stat ca;lc
Sensitivity =
Specificity =
LR (–) =
LR (+) =
PPV =
NPV=
Variable Kreatinin_kinase
Kreatinin Kinase
Classification variabl MCI
e MCI
Sample size 100
Positive group a 13 (13.00%)
Negative group b 87 (87.00%)
a
MCI = 1
b
MCI = 0
Disease prevalence (% 13.0
)
Youden index
Youden index J 0.9195
Associated criterion >69.1098
Sensitivity 100.00
Specificity 91.95
Criterion values and coordinates of the ROC curve [Hide]
Criterio Sensitivi 95% Specifici 95% +LR 95% -LR 95% +PV 95% -PV 95%
n ty CI ty CI CI CI CI CI
≥40.08 100.00 75.3 - 0.00 0.0 - 1.00 1.0 - 13.0 13.0 -
86 100.0 4.2 1.0 13.0
>40.08 100.00 75.3 - 2.30 0.3 - 1.02 1.0 - 0.00 13.3 12.9 - 100.
86 100.0 8.1 1.1 13.6 0
>42.23 100.00 75.3 - 4.60 1.3 - 1.05 1.0 - 0.00 13.5 13.0 - 100.
35 100.0 11.4 1.1 14.1 0
>43.93 100.00 75.3 - 6.90 2.6 - 1.07 1.0 - 0.00 13.8 13.2 - 100.
42 100.0 14.4 1.1 14.5 0
>44.52 100.00 75.3 - 9.20 4.1 - 1.10 1.0 - 0.00 14.1 13.3 - 100.
65 100.0 17.3 1.2 15.0 0
>45.34 100.00 75.3 - 11.49 5.7 - 1.13 1.0 - 0.00 14.4 13.5 - 100.
03 100.0 20.1 1.2 15.4 0
>45.99 100.00 75.3 - 13.79 7.3 - 1.16 1.1 - 0.00 14.8 13.7 - 100.
3 100.0 22.9 1.3 15.9 0
>46.54 100.00 75.3 - 16.09 9.1 - 1.19 1.1 - 0.00 15.1 14.0 - 100.
38 100.0 25.5 1.3 16.3 0
>46.71 100.00 75.3 - 18.39 10.9 - 1.23 1.1 - 0.00 15.5 14.2 - 100.
13 100.0 28.1 1.4 16.8 0
>46.82 100.00 75.3 - 20.69 12.7 - 1.26 1.1 - 0.00 15.9 14.5 - 100.
32 100.0 30.7 1.4 17.3 0
>49.56 100.00 75.3 - 22.99 14.6 - 1.30 1.2 - 0.00 16.3 14.7 - 100.
72 100.0 33.2 1.5 17.9 0
>51.20 100.00 75.3 - 25.29 16.6 - 1.34 1.2 - 0.00 16.7 15.0 - 100.
17 100.0 35.7 1.5 18.4 0
>51.43 100.00 75.3 - 27.59 18.5 - 1.38 1.2 - 0.00 17.1 15.3 - 100.
34 100.0 38.2 1.6 19.0 0
>51.50 100.00 75.3 - 29.89 20.5 - 1.43 1.2 - 0.00 17.6 15.7 - 100.
42 100.0 40.6 1.6 19.6 0
>51.59 100.00 75.3 - 32.18 22.6 - 1.47 1.3 - 0.00 18.1 16.0 - 100.
92 100.0 43.1 1.7 20.3 0
>53.27 100.00 75.3 - 34.48 24.6 - 1.53 1.3 - 0.00 18.6 16.4 - 100.
79 100.0 45.4 1.8 21.0 0
>53.45 100.00 75.3 - 36.78 26.7 - 1.58 1.3 - 0.00 19.1 16.8 - 100.
25 100.0 47.8 1.9 21.7 0
>53.56 100.00 75.3 - 39.08 28.8 - 1.64 1.4 - 0.00 19.7 17.2 - 100.
5 100.0 50.1 1.9 22.5 0
>53.65 100.00 75.3 - 41.38 30.9 - 1.71 1.4 - 0.00 20.3 17.6 - 100.
01 100.0 52.4 2.0 23.3 0
>53.90 100.00 75.3 - 43.68 33.1 - 1.78 1.5 - 0.00 21.0 18.1 - 100.
37 100.0 54.7 2.1 24.2 0
>54.79 100.00 75.3 - 45.98 35.2 - 1.85 1.5 - 0.00 21.7 18.6 - 100.
23 100.0 57.0 2.2 25.1 0
>55.62 100.00 75.3 - 48.28 37.4 - 1.93 1.6 - 0.00 22.4 19.1 - 100.
22 100.0 59.2 2.4 26.1 0
>56.42 100.00 75.3 - 50.57 39.6 - 2.02 1.6 - 0.00 23.2 19.6 - 100.
82 100.0 61.5 2.5 27.2 0
>56.68 100.00 75.3 - 52.87 41.9 - 2.12 1.7 - 0.00 24.1 20.2 - 100.
46 100.0 63.7 2.7 28.4 0
>56.78 100.00 75.3 - 55.17 44.1 - 2.23 1.8 - 0.00 25.0 20.9 - 100.
49 100.0 65.9 2.8 29.6 0
>56.89 100.00 75.3 - 57.47 46.4 - 2.35 1.8 - 0.00 26.0 21.6 - 100.
89 100.0 68.0 3.0 31.0 0
>57.43 100.00 75.3 - 59.77 48.7 - 2.49 1.9 - 0.00 27.1 22.3 - 100.
61 100.0 70.1 3.2 32.4 0
>61.51 100.00 75.3 - 62.07 51.0 - 2.64 2.0 - 0.00 28.3 23.1 - 100.
42 100.0 72.3 3.4 34.0 0
>61.68 100.00 75.3 - 64.37 53.4 - 2.81 2.1 - 0.00 29.5 24.0 - 100.
7 100.0 74.4 3.7 35.7 0
>62.13 100.00 75.3 - 66.67 55.7 - 3.00 2.2 - 0.00 31.0 25.0 - 100.
92 100.0 76.4 4.0 37.6 0
>63.36 100.00 75.3 - 68.97 58.1 - 3.22 2.4 - 0.00 32.5 26.0 - 100.
65 100.0 78.5 4.4 39.7 0
>64.24 100.00 75.3 - 71.26 60.6 - 3.48 2.5 - 0.00 34.2 27.2 - 100.
72 100.0 80.5 4.8 42.0 0
>65.37 100.00 75.3 - 73.56 63.0 - 3.78 2.7 - 0.00 36.1 28.5 - 100.
17 100.0 82.4 5.4 44.5 0
>65.40 100.00 75.3 - 75.86 65.5 - 4.14 2.9 - 0.00 38.2 29.9 - 100.
5 100.0 84.4 6.0 47.3 0
>65.64 100.00 75.3 - 78.16 68.0 - 4.58 3.1 - 0.00 40.6 31.5 - 100.
24 100.0 86.3 6.8 50.5 0
>65.87 100.00 75.3 - 80.46 70.6 - 5.12 3.3 - 0.00 43.3 33.3 - 100.
9 100.0 88.2 7.8 53.9 0
>67.11 100.00 75.3 - 82.76 73.2 - 5.80 3.7 - 0.00 46.4 35.4 - 100.
41 100.0 90.0 9.2 57.9 0
>67.90 100.00 75.3 - 85.06 75.8 - 6.69 4.1 - 0.00 50.0 37.7 - 100.
09 100.0 91.8 11.0 62.3 0
>68.42 100.00 75.3 - 87.36 78.5 - 7.91 4.6 - 0.00 54.2 40.5 - 100.
19 100.0 93.5 13.7 67.2 0
>69.05 100.00 75.3 - 89.66 81.3 - 9.67 5.2 - 0.00 59.1 43.8 - 100.
46 100.0 95.2 17.9 72.8 0
>69.10 100.00 75.3 - 91.95 84.1 - 12.4 6.1 - 0.00 65.0 47.7 - 100.
98 100.0 96.7 3 25.3 79.1 0
>70.16 92.31 64.0 - 93.10 85.6 - 13.3 6.1 - 0.08 0.01 - 66.7 47.6 - 98.8 92.5 -
41 99.8 97.4 8 29.4 3 0.5 81.5 99.8
>72.90 76.92 46.2 - 93.10 85.6 - 11.1 4.9 - 0.25 0.09 - 62.5 42.1 - 96.4 90.9 -
38 95.0 97.4 5 25.5 0.7 79.2 98.6
>73.24 69.23 38.6 - 94.25 87.1 - 12.0 4.8 - 0.33 0.1 - 64.3 41.7 - 95.3 90.1 -
95 90.9 98.1 5 30.4 0.7 81.9 97.9
>75.24 69.23 38.6 - 96.55 90.3 - 20.0 6.2 - 0.32 0.1 - 75.0 48.2 - 95.5 90.3 -
07 90.9 99.3 8 64.7 0.7 90.6 97.9
>76.51 61.54 31.6 - 97.70 91.9 - 26.7 6.4 - 0.39 0.2 - 80.0 48.8 - 94.4 89.5 -
48 86.1 99.7 7 112.5 0.8 94.4 97.1
>76.88 53.85 25.1 - 98.85 93.8 - 46.8 6.3 - 0.47 0.3 - 87.5 48.3 - 93.5 88.8 -
72 80.8 100.0 5 350.6 0.8 98.1 96.3
>77.45 38.46 13.9 - 98.85 93.8 - 33.4 4.2 - 0.62 0.4 - 83.3 38.8 - 91.5 87.5 -
74 68.4 100.0 6 264.2 1.0 97.5 94.3
>77.99 30.77 9.1 - 100.00 95.8 - 0.69 0.5 - 100. 90.6 87.1 -
5 61.4 100.0 1.0 0 93.3
>78.36 15.38 1.9 - 100.00 95.8 - 0.85 0.7 - 100. 88.8 86.3 -
19 45.4 100.0 1.1 0 90.9
>78.67 0.00 0.0 - 100.00 95.8 - 1.00 1.0 - 87.0 87.0 -
51 24.7 100.0 1.0 87.0
4.3. Kesimpulan:
Nilai Importancy
Secara klinis:
CER = 0,26 artinya kejadian kematian pada kelompok penggunaan placebo sebesar 26%
RR =0,46 artinya ACE inhibitor merupakan factor proteksi terjadinya kematian
RRR = 0,538 artinya pengurangan kematian pada penggunaan ACE Inhibitor sebesar 53,8%
di bandingkan Placebo.
Bermakna secara klinis bila RRR≥25%, sangat bermakna jika lebih dari 50%.
NNT = 7,14 artinya diperlukan pengobatan dengan ACE-i sevesar 7-8 orang untuk mencegah
satu kematian selama 2 tahun.
Secara statistic: pada uji Chi-square p = 0,126 >0,05 artinya perbedaan kematian antara
penggunaan ACE-i dan placebo tidak bermakna.
5.2.kesimpulan
Hasil penelitian penting dan bermakna secara klinis sebab kareba RRR>50% , hasil penelitian
tidak bermakna secara statistic.
Cases
Outcome
Chi-Square Tests
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 17.50.
Secara klinis
EER
CER
RR artinya
ABI artinya
RBI 1 (100%) artinya peluang sembuh pengguna enalapril+ASA 100% dibandingkan dengan
penggunaan isosorbid progerpi+diuretik
NNT artinya
6.2. Kesimpulan: